NRX Pharmaceuticals, Inc. - Common Stock (NRXP)

Nrx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing innovative therapies for patients with central nervous system disorders and critical medical conditions

The company is dedicated to addressing unmet medical needs through its research and development efforts, particularly in the areas of depression, anxiety, and other severe neuropsychiatric conditions. Nrx Pharmaceuticals' approach integrates cutting-edge science with a commitment to improving patient outcomes, leveraging both established and novel treatment modalities to better serve those affected by complex health challenges.